Sponsor or institution

Clinical trials and research at Biocad

• 11Clinical trials
• 3Countries

Newest trials

All recruiting trials (11)

• BCD-248 plus daratumumab in relapsed or refractory multiple myeloma

  This study tests whether adding BCD-248 to daratumumab helps people with relapsed or refractory multiple myeloma who have had prior lines of therapy.

  Recruiting at 16 sites Phase 3 Biocad · Homyel and 15 other locations · NCT07742215

• BCD-281 versus ocrelizumab for relapsing-remitting multiple sclerosis

  This study tests whether BCD-281 works as well and is as safe as ocrelizumab for adults 18–55 with relapsing‑remitting multiple sclerosis.

  Recruiting Phase 3 Biocad · Nizhny Novgorod · NCT07321093

• BCD-256 alone or with divozilimab for lupus skin lesions

  This will test whether BCD-256 by itself or together with divozilimab helps adults with mild-to-moderate systemic lupus who have active skin lesions.

  Recruiting Phase 1 Biocad · Saint Petersburg · NCT07136389

• BCD-236 plus chemotherapy for relapsed or metastatic triple negative breast cancer

  This trial will try BCD-236 together with chemotherapy to see if it helps people with relapsed or metastatic triple negative breast cancer whose tumors show AXL.

  Recruiting at 40 sites Phase 2 Biocad · Brest and 46 other locations · NCT07108309

• BCD-261 treatment for moderate to severe ulcerative colitis

  This trial tests whether different doses of BCD-261, an anti‑TL1A monoclonal antibody, can improve symptoms and inflammation in adults 18–75 with moderate to severe ulcerative colitis who have not responded to steroids, immunosuppressants, or biologics.

  Recruiting at 20 sites Phase 2 Biocad · Barnaul, Altayskiy Kray and 19 other locations · NCT07080034

• BCD-261 (anti‑TL1A) treatment for adults with moderate to severe Crohn's disease testing several dose regimens

  This trial will test whether different doses of the anti‑TL1A antibody BCD-261 help adults with moderate to severe Crohn's disease who have not responded to steroids, immunosuppressants, or biologics.

  Recruiting at 20 sites Phase 2 Biocad · Barnaul, Altayskiy Kray and 19 other locations · NCT07078994

• Investigating the safety and effects of BCD-261 in healthy individuals

  This study is testing a new drug called BCD-261 to see how safe it is and how it affects healthy men aged 18 to 45 after a single injection.

  Recruiting Phase 1 Biocad · Saint Petersburg · NCT06715540

• Comparing ANB-002 to standard treatment for hemophilia B

  This study is testing a new treatment called ANB-002 to see if it works as well as the standard treatment for adults with hemophilia B who have low FIX activity and no FIX inhibitors.

  Recruiting at 11 sites Phase 3 Biocad · Chelyabinsk and 13 other locations · NCT06700096

• Evaluating BCD-248 for treating relapsed or refractory multiple myeloma

  This study is testing a new treatment called BCD-248 to see if it can help people with relapsed or refractory multiple myeloma who have already tried other therapies.

  Recruiting at 7 sites Phase 2 Biocad · Kaliningrad and 19 other locations · NCT06668792

• Investigating ANB-002 for treating Hemophilia B

  This study is testing a new treatment called ANB-002 to see if it can safely help people with Hemophilia B manage their condition better.

  Recruiting at 17 sites Phase 1/2 Biocad · Homyel and 16 other locations · NCT06120582

• Investigating a new gene therapy for children with spinal muscular atrophy

  This study is testing a new gene therapy called ANB-004 to see if it can help young children with spinal muscular atrophy feel better and stay safe.

  Recruiting at 7 sites Phase 1/2 Biocad · Minsk and 6 other locations · NCT05747261

Quick answers

How many clinical trials run by Biocad are recruiting right now?

11, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in Russia (11 trials), Belarus (4 trials), Thailand (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 4, Phase 3: 3, Phase 1/2: 2, Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →